vidarabine has been researched along with Cryoglobulinemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharyya, J; Kimura, A; Mihara, K; Takihara, Y | 1 |
| Cacoub, P; Choquet, S; Decaux, O; Hermine, O; Jego, P; Karras, A; Pineton de Chambrun, M; Saadoun, D | 1 |
| Appel, GB; Radhakrishnan, J; Rosenstock, JL; Sherman, WH; Stern, L | 1 |
| Jacobs, MI; Mantha, S; Savage, DG | 1 |
| Enzenauer, RJ; Judson, PH | 2 |
| Zaja, F | 1 |
| Manns, MP; Rambusch, EG | 1 |
| Guillevin, L; Lhote, F | 1 |
1 review(s) available for vidarabine and Cryoglobulinemia
| Article | Year |
|---|---|
[Treatment of viral vasculitis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; Cyclophosphamide; Hepacivirus; Hepatitis B virus; Human T-lymphotropic virus 1; Humans; Immunization, Passive; Interferon-alpha; Parvovirus; Plasma Exchange; Vasculitis; Vidarabine | 1999 |
8 other study(ies) available for vidarabine and Cryoglobulinemia
| Article | Year |
|---|---|
Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Cyclophosphamide; Female; Humans; Immunoglobulin M; Livedo Reticularis; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Rituximab; Vidarabine | 2012 |
Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myeloablative Agonists; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine | 2013 |
Fludarabine treatment of cryoglobulinemic glomerulonephritis.
Topics: Adult; Cryoglobulinemia; Disease-Free Survival; Fatal Outcome; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; RNA, Viral; Vidarabine; Viral Load | 2002 |
Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia.
Topics: Allopurinol; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Diagnosis, Differential; Humans; Immunoglobulin G; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Rituximab; Vidarabine | 2005 |
Type II mixed cryoglobulinemia treated with fludarabine.
Topics: Antineoplastic Agents; Cryoglobulinemia; Humans; Male; Middle Aged; Remission Induction; Sjogren's Syndrome; Vidarabine | 1996 |
Fludarabine in the treatment of essential mixed cryoglobulinaemia.
Topics: Antineoplastic Agents; Cryoglobulinemia; Humans; Vidarabine | 1996 |
Purine analogues for treatment of refractory essential mixed cryoglobulinemia.
Topics: 2-Chloroadenosine; Cryoglobulinemia; Deoxyadenosines; Humans; Purines; Vidarabine | 1997 |
[Therapy of hepatitis C-associated extrahepatic diseases].
Topics: Antiviral Agents; Combined Modality Therapy; Cryoglobulinemia; Glomerulonephritis, Membranous; Hepatitis C; Humans; Vidarabine | 1998 |